LPO and craniosynostosis: As shown in Figure 3C(c,d), the levels of MDA were 2.4 ± 0.4, 2.3 ± 0.3, 4.2 ± 0.4, and 3.5 ± 0.4 nmol/mgprot, in the Sham, Sham+CSO, MCAO, and MCAO+CSO groups, respectively, and the levels of LPS were 0.4 ± 0.1, 0.4 ± 0.1, 0.8 ± 0.1, and 0.7 ± 0.1 μmol/gprot, in the Sham, Sham+CSO, MCAO, and MCAO+CSO groups, respectively; and significant effects for MDA and LPO levels were found across all four groups, (FMDA(3,20) = 35.47, pMDA= .001; FLPO(3,20) = 50.68, pLPO = .001).